Nucleic Acid Based Gene Therapy Market 2022 - Opportunities And Strategies – Global Forecast To 2030

The Business Research Company’s Nucleic Acid Based Gene Therapy Market 2022 - Opportunities And Strategies – Global Forecast To 2030

LONDON, GREATER LONDON, UK, July 7, 2022 /EINPresswire.com/ -- Major players operating in the nucleic acid-based gene therapy market are continuously collaborating or partnering with technology companies to integrate advanced technologies for the improvement of gene therapy. Advanced technologies such as artificial intelligence (AI) and big data are used for personalizing and manufacturing improved gene therapy. According to the nucleic acid based gene therapy market analysis, machine learning enables accelerated analysis of the sequenced data and enables effective prediction of the genetic alterations associated with a disease. This helps in reducing the time and effort required in the process of developing precision medicine. For instance, in September 2021, Mila, a Canada-based artificial intelligence research institute has partnered with Deep Genomics, a therapeutic artificial intelligence treatments provider.

The nucleic acid-based gene therapy market size is expected to grow from $4.73 billion in 2020 to $7.28 billion in 2025 at a rate of 9.0%. The nucleic acid-based gene therapy market share is then expected to grow at a CAGR of 15.4% from 2025 and reach $14.91 billion in 2030.

Read more on the Global Nucleic Acid Based Gene Therapy Market Report
https://www.thebusinessresearchcompany.com/report/nucleic-acid-based-gene-therapy-global-market

Increasing healthcare expenditure is predicted to upsurge the demand for the nucleic acid-based gene therapy market. The growth in healthcare expenditure is aiding governments and organizations to spend more on prescription drugs, hospitals, and physical & clinical services, thereby driving the nucleic acid-based gene therapy market. According to the National Health Expenditure Projections 2018-2027, national healthcare expenditure is expected to reach nearly $6.0 trillion by 2027 in the USA, growing at an average rate of 5.5% annually from 2018 to 2027. Furthermore, prescription drug spending is projected to grow by 6.1% annually during 2020-2027. Also, in terms of annual spending on approved gene therapies, it has reached $5.15 billion in 2020, and will increase to $25.3 billion by 2026. Thus, the rise in healthcare spending is to increase the nucleic acid based gene therapy market growth in the near future.

Major players covered in the global nucleic acid based gene therapy industry are Copernicus Therapeutics, Moderna Inc., Wave Life Sciences, Protagonist Therapeutics, Transgene.

TBRC’s nucleic acid-based gene therapy market research report is segmented by nucleic acid technology into anti-sense and anti-gene oligonucleotides, siRNA and RNA interference, gene transfer therapy, ribozymes, aptamers, others, by application into oncology, muscular dystrophy/ muscular disorders, rare diseases, others, by end user into hospitals and clinics, academic and research institutes.

Nucleic Acid Based Gene Therapy Market 2022 - By Nucleic Acid Technology (Anti-Sense and Anti-Gene Oligonucleotides, siRNA and RNA Interference, Gene Transfer Therapy, Ribozymes, Aptamers), By Application (Oncology, Muscular Dystrophy/ Muscular Disorders, Rare Diseases), By End User (Hospitals And Clinics, Academic And Research Institutes), And By Region, Opportunities And Strategies – Global Forecast To 2030 is one of a series of new reports from The Business Research Company that provides a nucleic acid based gene therapy market overview, forecast nucleic acid based gene therapy market size and growth for the whole market, nucleic acid based gene therapy market segments, geographies, nucleic acid based gene therapy market trends, nucleic acid based gene therapy market drivers, restraints, leading competitors’ revenues, profiles, and market shares.

Request for a Sample of the Global Nucleic Acid Based Gene Therapy Market Report
https://www.thebusinessresearchcompany.com/sample.aspx?id=5574&type=smp

Not what you were looking for? Here is a list of similar reports by The Business Research Company:
Cell Therapy Global Market Report 2022 – By Technique (Stem Cell Therapy, Cell Vaccine, Adoptive Cell Transfer (ACT), Fibroblast Cell Therapy, Chondrocyte Cell Therapy), By Therapy Type (Allogeneic Therapies, Autologous Therapies), By Application (Oncology, Cardiovascular Disease (CVD), Orthopedic, Wound Healing) – Market Size, Trends, And Global Forecast 2022-2026
https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

Gene Editing Global Market Report 2022 – By Technology (CRISPR, TALEN, ZFN), By End Users (Biotechnology, Pharmaceutical, Contract Research Organization), By Application (Animal Genetic Engineering, Plant Genetic Engineering, Cell Line Engineering) – Market Size, Trends, And Global Forecast 2022-2026
https://www.thebusinessresearchcompany.com/report/gene-editing-global-market-report

Microbiology Diagnostic Devices And Equipment Global Market Report 2022 – By Type (Laboratory Instruments, Microbiology Analysers), By End User (Hospitals, Diagnostic Centres, Customer Lab Service Providers, Academic Institutes, Research Institutes), By Laboratory Instruments (Incubators, Gram Stainers, Bacterial Colony Counters, Petri Dish Fillers, Automated Culture Systems), By Micro-Biology Analyzers (Microbiology Diagnostics Instruments, Microscopes), By Reagents (Pathogen-Specific Kits, General Reagents) – Market Size, Trends, And Global Forecast 2022-2026
https://www.thebusinessresearchcompany.com/report/microbiology-diagnostic-devices-and-equipment-global-market-report

About The Business Research Company?
The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.
Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Check out our:
LinkedIn: https://bit.ly/3b7850r
Twitter: https://bit.ly/3b1rmjS
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: http://blog.tbrc.info/

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
Twitter
LinkedIn